期刊文献+

高尿酸血症综合系统管理分析 被引量:11

Analysis on cooperative management for hyperuricemia in the community.
下载PDF
导出
摘要 目的评价社区系统管理对高尿酸血症人群的防治效果,探索高尿酸血症的社区健康促进对策,以促进患者积极的参与健康维护,降低高尿酸血症对人体的危害,避免心脑血管疾病的发生,提高生活质量。方法对2003年中山市居民2906人进行调查,发现高尿酸血症患者896例,对其进行综合干预。内容包括:上网登记、健康教育、指导用药、定期检测、不良生活习惯和行为干预。结果干预前、后896例患者的高尿酸血症相关知识、饮食情况间差异均有显著性意义(P<0.05),血尿酸、体质指数(BM I)、血压均值间差别有非常显著性差异(P<0.01)。结论社区综合系统管理对高尿酸血症具有较好的干预效果,加强社区综合系统管理应该成为全民健康政策的重要内容。 Objective To evaluate the effect of cooperative management for hyperuricemia in the community. Explore the health management measure of hyperuricemia in community, to accelerate the patient taker part in health management, to reduce the harm from the hyperuricemia to human body, to cut down incidence of cardiovascular diseases, to improve the quality of life. Methods From 2003 , 896 hyperuricemia patients wen found by a survey of a total population of 2906 dwellers in ZhongShan town. The cooperative management containing: web registration, health education, medicine guidance, periodical inspection, intervention lifestyle and diet . Results After intervention,896 patients had evident change about hyperuricemia awareness and rational dietary paltern , serum uric acid, BMI and blood pressure . The effect is in evidence ( p 〈0.01 ). Conclusion Cooperative management in the community has a better effect in hyperuriceroias. It should be important to enhance cooperative management in people's health policy.
作者 杨玉霞 刘勇
出处 《临床和实验医学杂志》 2006年第6期669-670,共2页 Journal of Clinical and Experimental Medicine
关键词 高尿酸血症 系统管理 效果评价 Hyperuricemia Cooperative management Effective evaluation
  • 相关文献

参考文献3

二级参考文献16

  • 1MatsuuraF,Yamashita S,Nakamura T,et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is lmked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism, 1998,47:929-93
  • 2Tsunoda S, Kamide K, Minami J, et al. Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and insulin-sensitizing agent. Am J Hypertens, 2002,15:697-701.
  • 3Culleton BF, Larson MG, Kannel WB, et al. Serum urid acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Int Med, 1999,131:7-13.
  • 4Bedir A, Topbas M, Tanyeri F, et al. Leptin might be a regulator of serum uric acid concentration in human. Jpn Heart J,2003, 44:527-536.
  • 5Costa A,Iguala I,Bedini J,et al. Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. Metabolism,2002,51:372-375.
  • 6Bo S, Cavallo-Perin P, Gentile L, et al. Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest,2001,31:318-321.
  • 7Francisco L, Callum S, Winggrove LF, et al. The glycolytic pathway to coronary heart disease: A hypothesis. Metabolism,1998,47:657-662.
  • 8Zao M, Nishio H, Lee MJ, et al. The C677 T mutation in the methylene tetrahydrofolte reductase gene increase serum uric acid in elderly men. J Hum Genet, 2000,45: 257-262.
  • 9Nietro FJ, Iribarren C, Gross MD, et al. Uric acid and serum antioxidant capacity: A reaction to atherosclerosis? Atherosclerosis,2000,148: 131-139.
  • 10Bickel C, Rupprecht HJ, Blankenbery S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol,2002,89:12-17.

共引文献284

同被引文献87

引证文献11

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部